McMillan Office’s Lam Research LRCX Stock Holding History

McMillan Office’s Portfolio LRCX Stock Details LRCX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$17.1K	Hold	80	–	–	﹤0.01%	355
2025 Q4	$13.7K	Buy	+80	New	+$12.4K	﹤0.01%	363

Other funds holding LRCX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

McMillan Office's LRCX Position: Q1 2026 in Review

McMillan Office held its Lam Research (LRCX) position steady in Q1 2026 at 80 shares worth $17.1K. The position accounts for ﹤0.01% of the portfolio, ranked #355.

McMillan Office first reported a position in LRCX in Q4 2025 and has held it in 2 quarters since. 2,630 funds tracked by Wall St. Rank hold LRCX as of Q1 2026.

McMillan Office held 80 shares of Lam Research worth $17.1K as of Q1 2026.
McMillan Office left its Lam Research share count unchanged in Q1 2026.
Lam Research made up ﹤0.01% of McMillan Office's portfolio in Q1 2026, its #355 holding.
McMillan Office first reported a position in Lam Research in Q4 2025 and has held it in 2 quarters since.
2,630 funds tracked by Wall St. Rank held Lam Research as of Q1 2026.

Based on McMillan Office's 13F filing for Q1 2026, filed 23 Apr 2026.